|  | Type of dominance | |
---|---|---|---|
 |  | Extended* | Absolute |
Celecoxib | Â | Â | Â |
Control joint pain | ↓ | 44.0% |  |
Control joint pain without adverse events | ↓ | 41.0% |  |
Nonselective NSAIDs | Â | Â | Â |
Control joint pain | ↑ | 67.5% | 82.5% |
Control joint pain without adverse events | ↑ | 49.5% | 63.0% |
Acetaminophen | Â | Â | Â |
Control joint pain | ↑ | 48.0% | 55.0% |
Control joint pain without adverse events | ↑ | 94.0% | it is not feasible |